lomustine has been researched along with Breast Cancer in 24 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Forty patients with advanced breast cancer, randomised to receive CMF or weekly low dose Epirubicin, were evaluated by UICC criteria of response and WHO toxicity criteria, in addition to three QoL instruments: the 'Qualitator' daily diary card, 4 weekly Nottingham Health Profile (NHP) and Linear Analogue Self-Assessment (LASA)." | 9.07 | Combination or mild single agent chemotherapy for advanced breast cancer? CMF vs epirubicin measuring quality of life. ( Bates, T; Baum, M; Dobbs, HJ; Ebbs, SR; Fallowfield, LJ; Fraser, SC, 1993) |
| "A total of 202 patients with advanced breast cancer were entered into two prospectively randomized Phase II trials conducted by the Eastern Cooperative Oncology Group, in an effort to identify promising agents and combinations for previously treated cases." | 6.65 | Phase II trials of Baker's antifol, bleomycin, CCNU, streptozotocin, tilorone, and 5-fluorodeoxyuridine plus arabinosyl cytosine in metastatic breast cancer. ( Colsky, J; Cummings, FJ; Gelman, R; Israel, L; Kuperminc, M; Skeel, RT; Tormey, D, 1981) |
| "Forty patients with advanced breast cancer, randomised to receive CMF or weekly low dose Epirubicin, were evaluated by UICC criteria of response and WHO toxicity criteria, in addition to three QoL instruments: the 'Qualitator' daily diary card, 4 weekly Nottingham Health Profile (NHP) and Linear Analogue Self-Assessment (LASA)." | 5.07 | Combination or mild single agent chemotherapy for advanced breast cancer? CMF vs epirubicin measuring quality of life. ( Bates, T; Baum, M; Dobbs, HJ; Ebbs, SR; Fallowfield, LJ; Fraser, SC, 1993) |
| "Forty-three patients with inoperable and/or recurring malignant gliomas and 30 patients with multiple recurring brain metastases were treated with a combination of adriamycine (45 mg/m 2 and 4-dimethyl-epipodophyllotoxin D-thenylidene (VM 26) (60 mg/m 2 for 2 days) and 1-(2-chloroethyl)-3-cyclohexyl-1-nitroso-urea (CCNU) (60 mg/m 2 for 2 days)." | 5.04 | Treatment of malignant gliomas and brain metastases in adults using a combination of adriamycine, VM 26, and CCNU. Results of a type II trial. ( Gautier, H; Huguenin, P; Lheritier, J; Mathé, G; Morin, P; Palangie, T; Parrot, R; Poisson, M; Pouillart, P, 1977) |
| "A total of 202 patients with advanced breast cancer were entered into two prospectively randomized Phase II trials conducted by the Eastern Cooperative Oncology Group, in an effort to identify promising agents and combinations for previously treated cases." | 2.65 | Phase II trials of Baker's antifol, bleomycin, CCNU, streptozotocin, tilorone, and 5-fluorodeoxyuridine plus arabinosyl cytosine in metastatic breast cancer. ( Colsky, J; Cummings, FJ; Gelman, R; Israel, L; Kuperminc, M; Skeel, RT; Tormey, D, 1981) |
| "Thirty-five patients with advanced breast cancer refractory to initial chemotherapy were randomized to receive two-drug doxorubicin-CCNU or three-drug doxorubicin-CCNU-vincristine (VCR) treatment." | 2.65 | Doxorubicin and CCNU with or without vincristine in patients with advanced refractory breast cancer. A randomized trial. ( Bateman, JR; Block, JB; Chlebowski, RT; Pugh, R; Weiner, JM, 1983) |
| "Our results of combined treatment of brain metastases are presented and available approaches to brain irradiation and chemotherapy are discussed." | 1.37 | [Brain metastasis in breast cancer]. ( Ivanov, VG; Korytova, LI; Masliukova, EA; Meshechkin, AV; Zhabuna, RM, 2011) |
| " The therapy is to be used effectfully only then, when indication, dosage and control of the patients are performed critically and exactly." | 1.26 | [Chemotherapy of malignant solid tumors]. ( Knöll, P; Siering, H, 1980) |
| "Three patients developed CNS metastasis while on treatment." | 1.26 | Adriamycin and 1-(2-chlorethyl)-3-cyclohexyl-1-nitrosourea (CCNU) in the treatment of metastatic breast cancer. ( Blumenschein, GR; Burgess, MA; Buzdar, AU; Hortobagyi, GN; Tashima, CK; Waterfield, WC, 1978) |
| "Untreated meningeal carcinomatosis is a uniformly fatal type of metastatic disease presenting with many protean signs and symptoms." | 1.26 | Meningeal carcinomatosis. Case report and review of the literature. ( Bender, J; Bramlet, D; Giliberti, J, 1976) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 19 (79.17) | 18.7374 |
| 1990's | 4 (16.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (4.17) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Korytova, LI | 1 |
| Meshechkin, AV | 1 |
| Zhabuna, RM | 1 |
| Masliukova, EA | 1 |
| Ivanov, VG | 1 |
| Siering, H | 1 |
| Knöll, P | 1 |
| Cummings, FJ | 1 |
| Gelman, R | 1 |
| Skeel, RT | 1 |
| Kuperminc, M | 1 |
| Israel, L | 3 |
| Colsky, J | 1 |
| Tormey, D | 1 |
| Conte, PF | 1 |
| Giaccone, G | 1 |
| Musella, R | 1 |
| Calciati, A | 1 |
| Chlebowski, RT | 1 |
| Pugh, R | 1 |
| Weiner, JM | 1 |
| Block, JB | 1 |
| Bateman, JR | 1 |
| Jones, AC | 1 |
| Stratford, IJ | 1 |
| Wilson, PA | 1 |
| Peckham, MJ | 1 |
| Fraser, SC | 1 |
| Dobbs, HJ | 1 |
| Ebbs, SR | 1 |
| Fallowfield, LJ | 1 |
| Bates, T | 1 |
| Baum, M | 1 |
| Kaba, SE | 1 |
| Kyritsis, AP | 1 |
| Hess, K | 1 |
| Yung, WK | 1 |
| Mercier, R | 1 |
| Dakhil, S | 1 |
| Jaeckle, KA | 1 |
| Levin, VA | 1 |
| Colleoni, M | 1 |
| Graiff, C | 1 |
| Nelli, P | 1 |
| Vicario, G | 1 |
| Sgarbossa, G | 1 |
| Pancheri, F | 1 |
| Manente, P | 1 |
| Band, PR | 1 |
| Canellos, GP | 1 |
| Sears, M | 1 |
| Pocock, SJ | 1 |
| Pouillart, P | 1 |
| Mathé, G | 1 |
| Palangie, T | 1 |
| Lheritier, J | 1 |
| Poisson, M | 1 |
| Huguenin, P | 1 |
| Gautier, H | 1 |
| Morin, P | 1 |
| Parrot, R | 1 |
| Waterfield, WC | 1 |
| Tashima, CK | 1 |
| Hortobagyi, GN | 1 |
| Blumenschein, GR | 1 |
| Buzdar, AU | 1 |
| Burgess, MA | 1 |
| Lokich, JJ | 1 |
| Skarin, AT | 1 |
| Hill, GJ | 1 |
| Johnson, RO | 1 |
| Metter, G | 1 |
| Wilson, WL | 1 |
| Davis, HL | 1 |
| Grage, T | 1 |
| Fletcher, WS | 1 |
| Golomb, FM | 1 |
| Cruz, AB | 1 |
| Hansen, M | 1 |
| Palshof, T | 1 |
| Osterlind, K | 1 |
| Hansen, HH | 1 |
| Mouridsen, H | 1 |
| Bramlet, D | 1 |
| Giliberti, J | 1 |
| Bender, J | 1 |
| Slavik, M | 2 |
| Mannes, P | 1 |
| Derriks, R | 1 |
| Moens, R | 1 |
| Laurent, C | 1 |
| Muss, HB | 1 |
| White, DR | 1 |
| Richards, F | 1 |
| Cooper, MR | 1 |
| Spurr, CL | 1 |
| Wasserman, TH | 1 |
| Carter, SK | 1 |
| Breau, JL | 1 |
| Morere, JF | 1 |
| Boaziz, C | 1 |
| Wang, QL | 1 |
| Tanneberger, S | 1 |
| Lam, HY | 1 |
| Ng, PK | 1 |
| Goldenberg, GJ | 1 |
| Wong, CM | 1 |
1 review available for lomustine and Breast Cancer
| Article | Year |
|---|---|
Clinical comparison of the nitrosoureas.
Topics: Animals; Antineoplastic Agents; Brain Neoplasms; Breast Neoplasms; Carmustine; Chemical Phenomena; C | 1975 |
8 trials available for lomustine and Breast Cancer
| Article | Year |
|---|---|
Phase II trials of Baker's antifol, bleomycin, CCNU, streptozotocin, tilorone, and 5-fluorodeoxyuridine plus arabinosyl cytosine in metastatic breast cancer.
Topics: Antineoplastic Agents; Bleomycin; Breast Neoplasms; Cytarabine; Drug Evaluation; Drug Therapy, Combi | 1981 |
Doxorubicin and CCNU with or without vincristine in patients with advanced refractory breast cancer. A randomized trial.
Topics: Breast Neoplasms; Clinical Trials as Topic; Doxorubicin; Drug Therapy, Combination; Female; Humans; | 1983 |
Combination or mild single agent chemotherapy for advanced breast cancer? CMF vs epirubicin measuring quality of life.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Ep | 1993 |
TPDC-FuHu chemotherapy for the treatment of recurrent metastatic brain tumors.
Topics: Adenocarcinoma; Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neop | 1997 |
Activity of combination chemotherapy in brain metastases from breast and lung adenocarcinoma.
Topics: Adenocarcinoma; Adult; Aged; Antidotes; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phyt | 1997 |
Phase II trial with bleomycin, CCNU, and streptozotocin in patients with metastatic cancer of the breast.
Topics: Adult; Aged; Bleomycin; Bone Neoplasms; Breast Neoplasms; Clinical Trials as Topic; Drug Evaluation; | 1977 |
Treatment of malignant gliomas and brain metastases in adults using a combination of adriamycine, VM 26, and CCNU. Results of a type II trial.
Topics: Adult; Aged; Brain Neoplasms; Breast Neoplasms; Clinical Trials as Topic; Doxorubicin; Drug Therapy, | 1977 |
Nitrosourea combination chemotherapy: 1-(2-chloroethyl)-3-(4-methyl cyclohexyl)-1-nitrosourea (methyl-CCNU) and cyclophosphamide.
Topics: Adult; Aged; Breast Neoplasms; Clinical Trials as Topic; Cyclophosphamide; Drug Administration Sched | 1975 |
15 other studies available for lomustine and Breast Cancer
| Article | Year |
|---|---|
[Brain metastasis in breast cancer].
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal; Antineoplastic Agents, Alkylating; Antineopl | 2011 |
[Chemotherapy of malignant solid tumors].
Topics: Bleomycin; Breast Neoplasms; Bronchial Neoplasms; Cyclophosphamide; Fluorouracil; Humans; Kidney Neo | 1980 |
Combination chemotherapy for metastatic brain tumors.
Topics: Adenocarcinoma; Brain Neoplasms; Breast Neoplasms; Carcinoma, Small Cell; Doxorubicin; Drug Therapy, | 1981 |
In vitro cytotoxic drug sensitivity testing of human tumour xenografts grown as multicellular tumour spheroids.
Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Cell Aggregation; Cell Division; Cell Line; Cispla | 1982 |
Adriamycin and 1-(2-chlorethyl)-3-cyclohexyl-1-nitrosourea (CCNU) in the treatment of metastatic breast cancer.
Topics: Adult; Aged; Bone Marrow; Brain Neoplasms; Breast Neoplasms; Doxorubicin; Drug Therapy, Combination; | 1978 |
Multimodal surgical adjuvant therapy for a broad spectrum of tumors in humans.?
Topics: Adult; Altretamine; Antineoplastic Agents; Bone Neoplasms; Breast Neoplasms; Carmustine; Colonic Neo | 1976 |
Combination chemotherapy with CCNU, melphalan, methotrexate, and prednisone (CAMP) in 35 patients with advanced breast cancer.
Topics: Administration, Oral; Adult; Aged; Antineoplastic Agents; Breast Neoplasms; Drug Therapy, Combinatio | 1977 |
Meningeal carcinomatosis. Case report and review of the literature.
Topics: Adult; Brain Neoplasms; Breast Neoplasms; Carcinoma; Female; Humans; Lomustine; Meninges; Methotrexa | 1976 |
Clinical studies with nitrosoureas in various solid tumors.
Topics: Adenocarcinoma; Breast Neoplasms; Carcinoma, Squamous Cell; Carmustine; Female; Genital Neoplasms, F | 1976 |
[Chemotherapy in primary and metastatic intrathoracic cancer].
Topics: Antineoplastic Agents; Breast Neoplasms; Bronchial Neoplasms; Cyclophosphamide; Doxorubicin; Drug Th | 1976 |
Adriamycin and CCNU in the treatment of advanced breast cancer.
Topics: Breast Neoplasms; Doxorubicin; Drug Therapy, Combination; Female; Humans; Lomustine; Nitrosourea Com | 1976 |
[Rapid complete regression of liver, brain and bone metastases from previously treated breast cancer, with combination of platin, fluorouracil and lomustine].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Brain Neoplasms; Breast Neopl | 1992 |
[Various doses cisplatin combined with multi-drug chemotherapy of malignant solid tumors].
Topics: Adenocarcinoma; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neop | 1989 |
[Possibilities and perspectives of adjuvant chemotherapy in malignant tumors].
Topics: Animals; Antineoplastic Agents; Bone Neoplasms; Breast Neoplasms; Drug Evaluation; Drug Screening As | 1989 |
Estrogen receptor-binding affinity and cytotoxic activity of three new estrogen-nitrosourea conjugates in human breast cancer cell lines in vitro.
Topics: Antineoplastic Agents; Binding, Competitive; Breast Neoplasms; Cell Line; Cell Survival; Cytosol; Do | 1987 |